US Approves Imatinib for Children With Ph+ Acute Lymphoblastic Leukemia
Imatinib has been approved to treat children newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia, the U.S. Food and Drug Administration announced Jan. 25.Imatinib, a tyrosine...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer & Oncology | Children | Food and Drug Administration (FDA) | Gleevec | Leukemia